PGD2, unlike other prostaglandins, inhibits myogenesis and its metabolites are increased in DMD patients; therefore, increased muscle fiber regeneration can be achieved by specific PGD2 inhibition. The gene discussed is HPGDS; the disease is Duchenne muscular dystrophy.